Hodgkin's disease during azathioprine therapy in a patient with autoimmune hepatitis [7];Maladiede Hodgkin au cours d'un traitement par azathioprine (Imurel®) pour hépatite chronique auto-immune

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 3, 2004, Pages 316-318

  Tchuenbou, Juliette ^a   De Muret, Anne ^a   Dumont, Pascal ^a   Bacq, Yannick ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISOLONE; PREDNISOLONE 3 SULFOBENZOATE; PROCARBAZINE; VINBLASTINE SULFATE; VINCRISTINE SULFATE; IMMUNOSUPPRESSIVE AGENT;

AGED; AUTOIMMUNE HEPATITIS; BLOOD CHEMISTRY; CANCER INCIDENCE; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG RESPONSE; FEMALE; HISTOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; LYMPHOCYTIC INFILTRATION; SERODIAGNOSIS; SEROLOGY; SYMPTOM; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER;

AGED; AZATHIOPRINE; FEMALE; HEPATITIS, AUTOIMMUNE; HODGKIN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 1942502185     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)94930-5     Document Type: Letter

References (17)

1. Garnier JL, Lebranchu Y, Dantal J, Bedrossian J, Cahen R, Assouline D, et al. Hodgkin's disease after transplantation. Transplantation 1996;61: 71-6.
2. Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 1989;47:293-6.
3. Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994;343:1249-52.
4. Fraser AG, Orchard TR, Robinson EM, Jewell DP. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 2002;16:1225-32.
5. Silman AJ, Petrie J, Hazleman B, Evans SJW. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 1988;47:988-92.
6. Wallace TM, Veldhuyzen van Zanten SJO. Frequency of use and standards of care for the use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease: a systematic review of the littérature and survey of canadian gastroenterologists. Can J Gastroenterol 2001;15:21-8.
7. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-97.
8. Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002;35:7-13.
9. Colburn KK, Cao JD, Krick EH, Mortensen SE, Wong LG. Hodgkin's lymphoma in a patient treated for wegener's granulomatosis with cyclophosphamide and azathioprine. J Rheumatol 1985;12:599-602.
10. Dayharsh GA, Loftus EV Jr, Sandborn WJ, Tremaine WJ, Zinsmeister AR, Witzig TE, et al. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology 2002;122:72-7.
11. Hecker R, Sheers R, Thomas D. Hodgkin's disease as a complication of Crohn's disease. Med J Aust 1978;2:603.
12. Pirotte JH. Development of Hodgkins disease in the course of active chronic hepatitis treated by immunosuppressive drugs. Am J Gastroenterol 1974;62:230-9.
13. Larvol L, Soule JC. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease. N Engl J Med 1994;331:883-4.
14. Aithal GP, Mansfield JC. Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment. Aliment Pharmacol Ther 2001;15:1101-8.
15. Lémann M, Bonhomme P, Bitoun A, Messing B, Modigliani R, Rambaud JC. Traitement de la maladie de Crohn par l'azathioprine ou la 6-mercaptopurine. Etude rétrospective chez 126 malades. Gastoenterol Clin Biol 1990;14:548-54.
16. Lewis JD, Sanford Schawrtz J, Lichtenstein GR. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. Gastroenterology 2000;118:1018-24.
17. Varoczy L, Gergely L, Zeher M, Szegedi G, Illes A. Malignant lymphoma-associated autoimmune diseases - a descriptive epidemiological study. Rheumatol Int 2002;22:233-7.